While I am not a sophisticated bio-tech investor...don't know all the nuances, but what I do see is that NWBO scares the hell out of a lot people, shorts, and other bio's. These continual attacks by so-called bio-tech experts with the shoddiest of credentials are truly running out of steam. While it's amazing that they can knock the price down significantly during intra-day trading, we are one irrefutable announcement away from a knock-out blow. I think that it is either German reimbursement, or the UK approval. Let Adam try to spin that one. In the meantime Maalox is the order of the day.